AbbVie Inc. (NEO:ABBV)
Canada flag Canada · Delayed Price · Currency is CAD
29.53
+0.11 (0.37%)
Apr 3, 2025, 9:30 AM EST

AbbVie Company Description

AbbVie Inc., a research-based biopharmaceutical company, engages in the research and development, manufacture, commercialization, and sale of medicines and therapies worldwide.

The company offers Humira, an injection for autoimmune and intestinal Behçet's diseases, generalized pustular psoriasis, and pyoderma gangrenosum; Skyrizi to treat autoimmune diseases, erythrodermic psoriasis, generalized pustular psoriasis, and palmoplantar pustulosis; Rinvoq to treat inflammatory diseases; Imbruvica for the treatment of adult patients with blood cancers; Venclexta/Venclyxto to treat blood cancers; Elahere to treat various cancer; and Epkinly to treat lymphoma.

It also provides facial injectables, plastics and regenerative medicine, body contouring, and skincare products; botox therapeutic to treat neurologic diseases; Vraylar to treat schizophrenia, bipolar disorder, and depressive disorder; Duopa and Duodopa to treat Parkinson's disease; Ubrelvy to treat migraine; and Qulipta for episodic and chronic migraine, as well as other neuroscience products.

In addition, the company offers Ozurdex for eye diseases; Lumigan/Ganfort and Alphagan/Combigan for the reduction of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension; Restasis to increase tear production; and other eye care products.

Further, it provides Mavyret/Maviret to treat chronic hepatitis C virus genotype 1-6 infection; Creon, a pancreatic enzyme therapy; and Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation.

The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.

AbbVie Inc.
Country United States
Founded 2012
Industry Drug Manufacturers - General
Sector Healthcare
Employees 55,000
CEO Robert Michael

Contact Details

Address:
1 North Waukegan Road
North Chicago, Delaware 60064-6400
United States
Phone 847 932 7900
Website abbvie.com

Stock Details

Ticker Symbol ABBV
Exchange Cboe Canada
Fiscal Year January - December
Reporting Currency USD
SIC Code 2836

Key Executives

Name Position
Richard A. Gonzalez Executive Chairman
Scott T. Reents Executive Vice President and Chief Financial Officer
Dr. Azita Saleki-Gerhardt Ph.D. Executive Vice President and Chief Operating Officer
Wulff-Erik von Borcke Senior Vice President and President of Oncology
Dr. Nicholas J. Donoghoe M.D. Executive Vice President and Chief Business and Strategy Officer
Tracie Haas Senior Vice President of Corporate Affairs
Greg Miley Senior Vice President of Government Affairs
Assil Omar Vice President and Chief Equity Officer
Dr. Latif Akintade M.D. Senior Vice President of Medical Affairs and Health Economics Outcomes Research
Jagjit Dosanjh-Elton FCCA, FCMA Senior Vice President and President of Neuroscience and Eye Care